Dissolution and bioavailability enhancement of glyburide

References

• Abd Elbary, A. A., H. F. Salem, and M. E. Maher. 2011. “In Vitro and In Vivo Evaluation of Glibenclamide Using Surface Solid Dispersion (SSD) Approach.” British Journal of Pharmacology and Toxicology 2: 51–62.
   Google Scholar
• Ahuja, N., O. P. Katare, and B. Singh. 2007. “Studies on Dissolution Enhancement and Mathematical Modelling of Drug Release of a Poorly Water-Soluble Drug Using Water Soluble Carriers.” European Journal of Pharmaceutics and Biopharmaceutics 65: 26–38.
   PubMed Web of Science ®Google Scholar
• Bandarkar, S. F., and S. K. Ibrahim. 2011. “Lyophilized Gliclazidepoloxamer, Solid Dispersions for Enhancement of In Vitro Dissolution and In Vivo Bioavailability.” International Journal Pharmacy Pharmaceutical Science 3, (Suppl 2): 122–7.
   Google Scholar
• Bertageri, G. V., and K. R. Makarla. 1996. “Characterization of Glyburide Polyethylene Glycol Solid Dispersions.” Drug Development and Industrial Pharmacy 22: 731–4.
   Web of Science ®Google Scholar
• Betageri, G. V., and K. R. Makarla. 1995. “Dissolution of Glyburide by Solid Dispersion and Lyophilization Techniques.” International Journal of Pharmaceutics 126: 155–60.
   Web of Science ®Google Scholar
• Bhise, S. D. 2011. “Ternary Solid Dispersions of Fenofibrate with Poloxamer 188 and TPGS for Enhancement of Solubility and Bioavailability.” International Journal of Research in Pharmaceutical and Biomedical Sciences 2(2): 583–95.
   Google Scholar
• Chauhan, B., S. Shimpi, and A. Paradkar. 2005. “Preparation and Evaluation of Glibenclamide-Polyglycolized Glycerides Solid Dispersions with Silicon Dioxide by Spray Drying Technique.” European Journal of Pharmaceutical Sciences 26, 219–30.
   PubMed Web of Science ®Google Scholar
• Chiou, W. L., and S. Riegelman. 1971. “Pharmaceutical Applications of Solid Dispersion System.” Journal of Pharmaceutical Sciences 60: 1281–302.
   PubMed Web of Science ®Google Scholar
• Craig, D. Q. M. 2002. “The Mechanisms of Drug Release from Solid Dispersions in Water Soluble Polymers.” International Journal of Pharmaceutical Sciences 231: 131–44.
   PubMed Web of Science ®Google Scholar
• Davis, S. N., and D. K. Granner. 1996. “Insulin, Oral Hypoglycemic Agents and the Pharmacology of Endocrine Pancreas.” In The Pharmacological Basis of Therapeutics, 9th Ed.; Gilman, A. G., Ed.; McGraw-Hill: New York; pp. 1487–518.
   Google Scholar
• Dordunoo, S. K., J. L. Ford, and M. H. Rubinstein. 1991. “Preformulation Studies on Solid Dispersions Containing Triamterene or Temazepam in Polyethylene Glycols or Gelucire 44/14 for Liquid Filling of Hard Gelatin Capsules.” Drug Development and Industrial Pharmacy 17: 1685–713.
   Web of Science ®Google Scholar
• Emilsson, H., S. Sjoberg, M. Svender, and I. Christenson. 1986. “High Performance Liquid Chromatographic Determination of Glibenclamide in Human Plasma and Urine.” J Chromatography 383: 93–102.
   PubMed Web of Science ®Google Scholar
• Grahnen, A. 1984. “Design of Bioavailability Studies.” Pharmacy International 5: 100–3.
   Google Scholar
• Higuchi, T., and K. A. Connors. 1965. “Phase Solubility Techniques.” Advances in Analytical Chemistry and Instrumentation 4: 117–212.
   Google Scholar
• Leuner, C., and J. Dressman. 2000. “Improving Drug Solubility for Oral Delivery Using Solid Dispersions.” European Journal of Pharmaceutics and Biopharmaceutics 50: 47–60.
   PubMed Web of Science ®Google Scholar
• Lin, C. W., and T. M. Cham. 1996. “Effect of Particle Size on the Available Surface Area of Nifedipine from Nifedipine–Polyethylene Glycol 6000 Solid Dispersions.” International Journal of Pharmaceutical Sciences 127: 261–72.
   Web of Science ®Google Scholar
• Liu, C., and K. G. Desai. 2005. “Characteristics of rofecoxib-polyethylene Glycol 4000 Solid Dispersions and Tablets Based on Solid Dispersions.” Pharmaceutical Development Technology 10: 467–77.
   PubMed Web of Science ®Google Scholar
• Lobenberg, L., R. Kramer, J. Shah, V. P. Amidon, and G. L. Dressman. 2000. “Dissolution Testing as Prognostic Tool for Oral Drug Absorption: Dissolution Behavior of Glibenclamide.” Pharmaceutical Research 17: 439–44.
   PubMed Web of Science ®Google Scholar
• Massik, E., M. A. Darwish, I. A. Hassan, and L. K. El-Khordagui. 1996. “Development of a Dissolution Medium for Glibenclamide.” International Journal of Pharmacy 140: 69–76.
   Web of Science ®Google Scholar
• Passerini, N., B. Perissutti, M. Moneghini, D. Voinovich, B. Albertini, C. Cavallari, and L. Rodriguez. 2002. “Characterization of Carmazepinegelucire 50/13 Microparticles Prepared by a Spray-Congealing Process Using Ultrasounds.” Journal of Pharmaceutical Sciences 91, 699–707.
   PubMed Web of Science ®Google Scholar
• Rajebahadur, M., H. Zia, A. Nues, and C. Lee. 2006. “Mechanistic Study of Solubility Enhancement of Nifedipine Using Vitamin E TPGS or Solutol HS-15.” Drug Delivery 13: 201–6.
   PubMed Web of Science ®Google Scholar
• Serajuddin, A. 1999. “Solid Dispersion of Poorly Water Soluble Drugs: Early Promises, Subsequent Problems and Recent Breakthroughs.” International Journal of Pharmacuetical Sciences 88: 1058–66.
   PubMed Web of Science ®Google Scholar
• Sharma, D. K., and S. B. Joshi. 2007. “Physicochemical Properties of Gelucires.” Asian Journal of Pharmaceutics 1: 1–11.
   Google Scholar
• Simonelli, A. P., S. C. Mehta, and W. I. Higuchi. 1969. “Dissolution Rates of High Energy polyvinylpyrrolidone-sulfathiazole Coprecipitates.” Journal of Pharmaceutical Sciences 58: 538–49.
   PubMed Web of Science ®Google Scholar
• Surana, R., R. Thakur, and J. Zhu. 2006. “Effectiveness of Vitamin E TPGS, PVP and PVP-VA in Solid Dispersions of Low Solubility Drugs.” Paper presented at the AAPS Annual Meeting and Exposition, San Antonio, TX, October 29–November 2.
   Google Scholar
• Tashtoush, B.M., Z.S. Al-Qashi, and N.M. Najib, 2004. “In vitro and in vivo evaluation of glibenclamide in solid dispersion systems.” Drug Development and Industrial Pharmacy, 30: 601–7.
   PubMed Web of Science ®Google Scholar
• Urbanetz, N. A., and B. C. Lippold. 2005. “Solid Dispersions of nimodipine and polyethylene glycol-2000: Dissolution Properties and Physicochemical Characterisation.” European Journal of Pharmaceutics and Biopharmaceutics 59: 107–18.
   PubMed Web of Science ®Google Scholar
• Varma, M. V., and R. Panchagnula. 2005. “Enhanced Oral Paclitaxel Absorption with Vitamin E-TPGS: Effect on Solubility and Permeability In Vitro, In Situ and In Vivo.” European Journal of Pharmaceutical Sciences 25: 445–53.
   PubMed Web of Science ®Google Scholar
• Wei, H., C. Dalton, M. Di Maso, I. Kanfer, and R. Löbenberg. 2008. “Physicochemical Characterization of Five Glyburide Powders: A BCS Based Approach to Predict Oral Absorption.” European Journal of Pharmaceutics and Biopharmaceutics 69: 1046–56.
   PubMed Web of Science ®Google Scholar
• Wei, H., and R. Lobenberg. 2006. “Biorelevant Dissolution Media as a Predictive Tool for Glyburide a Class II Drug.” European Journal of Pharmaceutical Sciences 29: 45–52
   PubMed Web of Science ®Google Scholar